GMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbH

GMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbH is a German company based in Berlin. Its name translates as the Society for Medical Innovation – Haematology and Oncology, and its own website describes it as a sponsor and service platform for clinical research in haematology and medical oncology. In other words, GMIHO positions itself in the clinical-research value chain: it supports the planning, sponsorship and operational delivery of studies in blood cancers and related oncological indications, rather than acting as a hospital, a pharmaceutical manufacturer or a pure technology vendor. The company is registered in Germany and operates from Berlin. Publicly available structured data about the entity is thin: Wikidata records it simply as a company in Berlin, Germany, and the official website was in maintenance mode at the time of research, showing only a placeholder notice. No founding year, founder names, ownership structure, executive team, product portfolio or financial details could be verified from the supplied evidence, and none are asserted here. Because the organisation is a small, specialised service provider rather than a consumer-facing brand, its visibility is largely limited to the clinical-trial and haematology/oncology research community in Germany. Its relevance lies in the niche it occupies: acting as a sponsor and service partner for investigator-initiated and industry-supported studies in a therapeutic area where specialised operational and regulatory expertise is required. This dossier therefore remains deliberately conservative. It records the verified identity, location, sector and self-description of GMIHO, and flags that further details — history, leadership, study portfolio and corporate affiliations — require additional sources before they can be stated as fact.

GMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbH is a German company located in Berlin. The available evidence does not include a founding date, founding story, ownership history or list of corporate milestones. What can be stated is its self-description: the official website presents GMIHO as a sponsor and service platform for clinical research in haematology and medical oncology. This places the company in the specialised clinical-research services sector, supporting studies in blood cancers and oncological indications. At the time of research, the official website was in maintenance mode and displayed only a placeholder message, so no further corporate history, leadership or portfolio information could be drawn from it. Wikidata records the entity only as a company in Berlin, Germany. Consequently, this history section is intentionally limited: it records the verified identity, location and sector of GMIHO and does not speculate about its origins, growth, partnerships or current scale. A fuller history would require additional primary or secondary sources such as commercial-register filings, company announcements or clinical-trial registry entries.

Specialised sponsor and service platform for clinical research in haematology and medical oncology, based in Berlin, Germany.

• Sponsor and service platform for clinical research in haematology and medical oncology

  GMIHO describes itself as a sponsor and service platform for clinical research in haematology and medical oncology.

1. 1GMIHO official websitegmiho.de
2. 2Wikidata: GMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbHwikidata.org